NovaBay Pharmaceuticals
NBY
NBY
17 hedge funds and large institutions have $2.37M invested in NovaBay Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$119K |
| 2 |
OL
Orbitronix LP
Newport Beach,
California
|
+$62.7K |
| 3 |
Goldman Sachs
New York
|
+$38K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$36.2K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$33.5K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Invesco
Atlanta,
Georgia
| – | -$22K | -1 | Closed |
|
27
Wells Fargo
San Francisco,
California
| – | -$3K | – | – |
|
28
Citigroup
New York
| – | -$3K | – | – |
|
|
EWA
29
EP Wealth Advisors
Torrance,
California
| – | -$16K | – | – |
|